Peripheral Iv Catheter Market Size, Share, Growth, and Industry Analysis, Types (Short PIVC, Integrated/closed PIVC), Applications (Hospitals, Ambulatory surgical centers, Clinics, Home use, Others), and Regional Insights and Forecast to 2035

Peripheral Iv Catheter Market Size

Global Peripheral Iv Catheter Market size was USD 4750 Million in 2025 and is projected to reach USD 5090 Million in 2026, further growing to USD 5440 Million in 2027 and USD 9350 Million by 2035, exhibiting a CAGR of 7% during the forecast period from 2026 to 2035. The market is expanding steadily because hospitals, clinics, and ambulatory care centers continue increasing the use of intravenous therapy systems for surgeries, hydration support, emergency care, and chronic disease treatment management.

The US Peripheral Iv Catheter Market continues showing strong growth because of rising hospitalization rates, expanding outpatient procedures, and increasing focus on patient safety technologies. Nearly 63% of healthcare providers in the United States are now using integrated safety catheter systems to reduce bloodstream infection risks and improve treatment efficiency. Around 41% of hospitals have increased investments in antimicrobial catheter products and advanced stabilization systems. Demand for home infusion therapy has also increased by almost 29%, supporting higher adoption of portable and safer peripheral IV catheter solutions across the country.

Key Findings

• Market Size: Valued at USD 4750 Million in 2025, projected to touch USD 5090 Million in 2026, USD 5440 Million in 2027, and USD 9350 Million by 2035 at a CAGR of 7%.
• Growth Drivers: Nearly 68% hospital patients require IV therapy, while 54% healthcare facilities use advanced safety catheter technologies.
• Trends: Around 39% hospitals adopt antimicrobial catheters and 34% healthcare providers expand home infusion treatment services globally.
• Key Players: B. Braun Melsungen AG, Smith Medical, Terumo Corporation, Inc., BD, Bard Acess.
• Regional Insights: North America holds 38% share, Europe 28%, Asia-Pacific 25%, and Middle East & Africa 9% of market demand.
• Challenges: Nearly 29% catheter failures occur due to infiltration issues, while 24% healthcare facilities report infection-related concerns.
• Industry Impact: Around 44% investments target safety IV systems and 31% focus on antimicrobial catheter technology improvements.
• Recent Developments: Nearly 32% improvement in blood control systems and 28% better stabilization efficiency achieved through product innovations.

The Peripheral Iv Catheter Market is becoming more technology-focused as healthcare providers continue prioritizing safer and more efficient intravenous treatment systems. Manufacturers are increasingly developing integrated safety solutions, antimicrobial materials, and advanced stabilization technologies to improve patient outcomes, reduce complications, and support growing demand across hospitals, clinics, ambulatory centers, and home healthcare environments.

One unique aspect of the Peripheral Iv Catheter Market is the growing shift toward integrated and closed catheter systems designed specifically to reduce bloodstream infections and accidental blood exposure. Healthcare providers are also focusing heavily on patient comfort, with increasing adoption of softer catheter materials and advanced stabilization devices for long-term intravenous therapy support.

Peripheral Iv Catheter Market Trends

The Peripheral Iv Catheter Market is growing steadily because hospitals and healthcare centers continue to increase the use of intravenous therapy for emergency care, surgeries, hydration support, and long-term treatment management. Nearly 68% of hospitalized patients require peripheral IV catheter insertion during treatment procedures, making these devices one of the most widely used medical consumables worldwide. Around 54% of healthcare facilities are now adopting integrated or closed PIVC systems to reduce infection risks and improve patient safety. The demand for home healthcare services has also increased by nearly 33%, supporting higher usage of portable and easy-to-use peripheral IV catheter systems. About 41% of clinicians prefer safety-engineered catheters because they help reduce needle-stick injuries and improve procedural efficiency. Advanced catheter stabilization technologies are being adopted by nearly 36% of hospitals to lower catheter failure rates and improve patient comfort. The Peripheral Iv Catheter Market is also seeing rising demand from ambulatory surgical centers as outpatient procedures continue expanding globally. Healthcare providers are focusing more on infection prevention, with nearly 39% of facilities increasing investments in antimicrobial catheter technologies and closed IV systems for better clinical outcomes.

Peripheral Iv Catheter Market Dynamics

OPPORTUNITY

Growing demand for home healthcare services

The increasing preference for home-based treatment is creating strong opportunities for the Peripheral Iv Catheter Market. Nearly 37% of chronic care patients now prefer home infusion therapy because it improves comfort and reduces hospital visits. Around 32% of healthcare providers are investing in portable IV catheter technologies to support remote patient monitoring and long-term intravenous treatments. Demand for easy-to-handle catheter systems is also increasing among elderly patients and post-surgery recovery programs.

DRIVERS

Rising hospitalization and surgical procedures

The growing number of hospital admissions and surgical procedures continues to drive the Peripheral Iv Catheter Market. Nearly 64% of inpatient treatments involve intravenous therapy support during hospitalization. Around 46% of surgical procedures now require advanced catheter systems for fluid delivery and medication management. Healthcare facilities are also increasing adoption of safety IV catheters to reduce infection rates and improve clinical workflow efficiency.

RESTRAINTS

"Catheter-related complications and infection concerns"

Complications related to catheter use remain a key restraint for the Peripheral Iv Catheter Market. Nearly 29% of peripheral IV catheter failures occur because of vein irritation, infiltration, or catheter displacement. Around 24% of healthcare professionals report concerns regarding bloodstream infections associated with improper catheter handling and prolonged catheter use. These complications increase replacement frequency and raise pressure on healthcare systems to improve patient monitoring standards.

CHALLENGE

"Increasing pressure to improve patient safety standards"

Healthcare providers continue facing challenges in maintaining safe and effective catheter management practices. Nearly 34% of hospitals are struggling with catheter replacement costs and staff training requirements related to advanced IV technologies. Around 27% of healthcare facilities report difficulties in maintaining consistent infection control practices during high patient volume periods. Rising expectations regarding patient safety and procedural accuracy are pushing manufacturers to improve product performance continuously.

Segmentation Analysis

The Peripheral Iv Catheter Market is segmented by type and application, with growing adoption across hospitals, ambulatory surgical centers, clinics, and home healthcare environments. Increasing use of integrated catheter technologies and rising demand for minimally invasive treatment procedures are supporting market expansion globally. The Global Peripheral Iv Catheter Market size was USD 4750 Million in 2025 and is projected to reach USD 5090 Million in 2026, further growing to USD 5440 Million in 2027 and USD 9350 Million by 2035, exhibiting a CAGR of 7% during the forecast period from 2026 to 2035.

By Type

Short PIVC

Short PIVC systems remain widely used because they support fast intravenous access for hydration, medication delivery, and emergency treatments. Nearly 61% of healthcare facilities continue using short PIVC devices due to ease of insertion and lower procedural complexity. Hospitals increasingly prefer advanced stabilization systems to improve patient comfort and reduce catheter replacement frequency.

Short PIVC held the largest share in the Peripheral Iv Catheter Market, accounting for USD 3054 Million in 2026, representing 60% of the total market. This segment is expected to grow at a CAGR of 6.8% from 2026 to 2035, driven by increasing hospital admissions, emergency care procedures, and rising intravenous therapy demand.

Integrated/closed PIVC

Integrated and closed PIVC systems are gaining strong popularity because healthcare providers are focusing heavily on infection prevention and patient safety improvements. Nearly 48% of modern healthcare centers now prefer closed catheter systems because they reduce blood exposure risks and improve clinical efficiency. Demand is also increasing due to rising awareness regarding catheter-associated complications.

Integrated/closed PIVC accounted for USD 2036 Million in 2026, representing 40% of the global Peripheral Iv Catheter Market share. This segment is projected to grow at a CAGR of 7.3% during the forecast period because of increasing adoption of safety-engineered IV catheter systems and infection control initiatives.

By Application

Hospitals

Hospitals remain the largest application segment in the Peripheral Iv Catheter Market because intravenous therapy is widely required across emergency departments, surgical units, and intensive care facilities. Nearly 72% of inpatient treatments involve peripheral IV catheter usage for medication administration and fluid management support.

Hospitals held the largest market share, accounting for USD 2290 Million in 2026, representing 45% of the total market. This application segment is expected to grow at a CAGR of 7.1% from 2026 to 2035 due to increasing hospitalization rates and growing surgical procedure volumes.

Ambulatory Surgical Centers

Ambulatory surgical centers are rapidly increasing adoption of peripheral IV catheter systems because outpatient procedures continue growing globally. Nearly 38% of minimally invasive surgeries performed in ambulatory facilities now require advanced IV catheter technologies for medication delivery and procedural support.

Ambulatory Surgical Centers accounted for USD 1171 Million in 2026, representing 23% of the global market share. This segment is forecast to grow at a CAGR of 7.2% during the forecast period because of increasing outpatient treatment demand and faster procedural turnover.

Clinics

Clinics continue expanding the use of peripheral IV catheters for vaccination programs, hydration therapy, and outpatient medication administration. Nearly 31% of primary care clinics are now integrating safer catheter technologies to improve patient care efficiency and reduce treatment complications.

Clinics accounted for USD 763 Million in 2026, representing 15% of the Peripheral Iv Catheter Market share. The segment is expected to grow at a CAGR of 6.7% because of increasing outpatient care visits and rising chronic disease management requirements.

Home use

Home use applications are becoming increasingly important because patients are preferring home infusion therapy and remote healthcare support. Nearly 28% of long-term intravenous treatments are now shifting toward home healthcare settings due to convenience and lower hospitalization requirements.

Home use represented USD 611 Million in 2026, accounting for 12% of the total market. This application segment is projected to grow at a CAGR of 7.5% due to rising elderly populations and increasing demand for home healthcare services.

Others

Other healthcare environments including rehabilitation centers and specialty treatment facilities continue adopting peripheral IV catheter systems for medication delivery and supportive care treatments. Nearly 18% of specialty care providers now prefer integrated catheter technologies to improve treatment efficiency and patient monitoring.

Others accounted for USD 255 Million in 2026, representing 5% of the market share. The segment is forecast to grow at a CAGR of 6.4% during the forecast period because of expanding specialty healthcare services and supportive treatment programs.

Peripheral Iv Catheter Market Regional Outlook

The Peripheral Iv Catheter Market is expanding steadily across major healthcare regions because of rising hospitalization rates, increasing chronic disease management, and growing adoption of advanced intravenous therapy systems. The Global Peripheral Iv Catheter Market size was USD 4750 Million in 2025 and is projected to reach USD 5090 Million in 2026, further increasing to USD 5440 Million in 2027 and USD 9350 Million by 2035, exhibiting a CAGR of 7% during the forecast period from 2026 to 2035. Regional healthcare investments, patient safety initiatives, and rising demand for minimally invasive treatment procedures continue supporting market expansion worldwide.

North America

North America continues leading the Peripheral Iv Catheter Market because of strong hospital infrastructure, advanced healthcare technologies, and rising surgical procedures. Nearly 71% of inpatient treatments in the region require intravenous therapy support. Around 58% of healthcare facilities are using integrated or closed PIVC systems to reduce bloodstream infections and improve patient safety. Demand for safety-engineered catheters is also increasing steadily across hospitals and ambulatory care centers.

North America held the largest share in the Peripheral Iv Catheter Market, accounting for USD 1934 Million in 2026, representing 38% of the total market. This regional market is expected to grow at a CAGR of 7.1% from 2026 to 2035, driven by increasing hospital admissions, strong healthcare spending, and growing adoption of advanced intravenous catheter technologies.

Europe

Europe remains a significant market for peripheral IV catheter systems because healthcare providers continue focusing on infection prevention and patient care quality. Nearly 49% of hospitals in the region have increased usage of closed IV catheter technologies to reduce treatment complications. Around 36% of healthcare centers are investing in antimicrobial catheter products and advanced stabilization systems to improve clinical efficiency.

Europe accounted for USD 1425 Million in 2026, representing 28% of the global Peripheral Iv Catheter Market share. The region is projected to grow at a CAGR of 6.8% during the forecast period because of rising elderly populations, increasing chronic disease cases, and strong healthcare modernization initiatives.

Asia-Pacific

Asia-Pacific is witnessing rapid growth in the Peripheral Iv Catheter Market due to increasing healthcare infrastructure development and rising patient populations. Nearly 43% of hospitals in the region are expanding intravenous therapy capabilities to support growing treatment demand. Around 39% of healthcare providers are adopting safer and cost-effective catheter technologies for emergency care and surgical procedures.

Asia-Pacific held USD 1273 Million in 2026, representing 25% of the total market share. This region is expected to grow at a CAGR of 7.5% from 2026 to 2035 because of rising healthcare investments, expanding hospital networks, and growing awareness regarding infection prevention practices.

Middle East & Africa

The Middle East & Africa Peripheral Iv Catheter Market is gradually expanding due to improving healthcare access and increasing hospital capacity development. Nearly 27% of healthcare providers in the region are upgrading intravenous therapy systems to improve patient care efficiency. Demand for disposable and safety IV catheter products is also rising steadily across public and private healthcare facilities.

Middle East & Africa accounted for USD 458 Million in 2026, representing 9% of the Peripheral Iv Catheter Market share. This regional market is projected to grow at a CAGR of 6.3% during the forecast period because of increasing healthcare investments and rising awareness regarding safe intravenous therapy management.

List of Key Peripheral Iv Catheter Market Companies Profiled

Investment Analysis and Opportunities in Peripheral Iv Catheter Market

The Peripheral Iv Catheter Market is attracting strong investment activity because healthcare providers are focusing more on patient safety, infection prevention, and advanced intravenous therapy technologies. Nearly 44% of medical device investments in vascular access systems are now directed toward safety-engineered and integrated catheter products. Around 37% of healthcare facilities are increasing procurement budgets for closed PIVC systems to reduce catheter-associated complications and improve treatment efficiency. Investments in antimicrobial coating technologies have increased by almost 31% as hospitals continue working toward lower infection rates. Home healthcare services are also creating new opportunities, with nearly 34% of healthcare organizations expanding remote intravenous treatment programs. The market is seeing rising investment in automation and digital monitoring systems, as around 28% of hospitals are integrating smart infusion and catheter tracking solutions. Emerging economies are becoming attractive investment destinations because healthcare infrastructure spending has increased by more than 40% across several developing regions. Manufacturers are also increasing investments in lightweight catheter materials and improved stabilization technologies to support patient comfort and reduce catheter failure rates.

New Products Development

The Peripheral Iv Catheter Market is experiencing continuous product development focused on improving patient safety, comfort, and clinical efficiency. Nearly 42% of newly launched IV catheter products now include integrated blood control features to reduce blood exposure during insertion procedures. Around 39% of manufacturers are developing antimicrobial catheter systems to help minimize infection risks in hospital environments. Advanced catheter stabilization products are also gaining popularity, with nearly 33% of healthcare providers preferring devices designed to reduce accidental dislodgement. Companies are increasingly introducing softer catheter materials that improve patient comfort and lower vein irritation rates. About 29% of new product innovations are focused on improving catheter visibility and insertion accuracy for healthcare professionals. Portable and home-use compatible catheter systems are also becoming more common because demand for home healthcare services continues growing globally. Several manufacturers are now integrating digital monitoring compatibility into catheter products to improve treatment tracking and patient management efficiency.

Recent Developments

• BD: In 2025, the company expanded production of integrated safety IV catheters, improving blood control efficiency by nearly 32% and reducing insertion-related exposure risks across hospital environments.
• B. Braun Melsungen AG: In 2025, the company introduced advanced catheter stabilization technology that improved patient comfort levels by approximately 28% and reduced accidental catheter dislodgement incidents in healthcare facilities.
• Terumo Corporation, Inc.: In 2025, the company increased focus on antimicrobial catheter development, with healthcare testing programs showing nearly 26% lower infection-related complications during intravenous therapy procedures.
• Smith Medical: In 2025, the company upgraded its peripheral IV catheter portfolio with improved needle safety mechanisms that helped reduce needle-stick injury risks by around 24% among healthcare workers.
• Tangent Medical: In 2025, the company expanded distribution of closed PIVC systems across ambulatory care centers, contributing to nearly 21% improvement in procedural efficiency during outpatient treatments.

Report Coverage

The Peripheral Iv Catheter Market report provides detailed analysis of market growth patterns, technological developments, competitive landscape, and healthcare adoption trends across multiple regions and application areas. The report studies increasing demand for intravenous therapy systems across hospitals, clinics, ambulatory surgical centers, and home healthcare services. Nearly 68% of hospitalized patients globally continue requiring peripheral intravenous therapy during treatment procedures, making IV catheter systems essential for modern healthcare operations.

The report includes segmentation analysis based on type and application, highlighting strong growth in integrated and closed PIVC systems because healthcare providers are focusing heavily on infection prevention and patient safety. Around 54% of hospitals are now adopting advanced safety catheter systems to improve procedural outcomes and reduce bloodstream infection risks. The report also examines rising demand for short PIVC systems used in emergency medicine, surgical procedures, and chronic disease management.

Regional analysis within the report covers North America, Europe, Asia-Pacific, and Middle East & Africa. North America leads the market because of strong healthcare infrastructure and high adoption of advanced intravenous technologies, while Asia-Pacific is showing rapid expansion due to increasing healthcare investments and hospital development programs. Nearly 43% of hospitals in developing regions are increasing investments in intravenous therapy technologies to improve patient care standards.

The report further evaluates investment opportunities, product innovation trends, and manufacturer strategies focused on antimicrobial coatings, integrated blood control technologies, and improved catheter stabilization systems. Nearly 39% of medical device companies are increasing research efforts toward infection-resistant IV catheter solutions. The study also highlights growing demand for home healthcare infusion therapies, with almost 34% of healthcare providers expanding remote treatment support services globally.